Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.50+0.11 (+1.49%)
At close: 04:00PM EDT
7.50 0.00 (0.00%)
After hours: 05:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
303,632
326,551
475,824
356,071
0
Cost of revenue
59,450
57,591
37,667
17,078
-
Gross profit
244,182
268,960
438,157
338,993
-
Operating expenses
Research development
242,530
363,105
142,759
94,188
110,239
Selling general and administrative
179,075
169,713
139,079
137,037
94,177
Total operating expenses
421,605
532,818
281,838
231,225
204,416
Operating income or loss
-177,423
-263,858
156,319
107,768
-204,416
Interest expense
26,280
22,959
21,166
17,601
9,684
Total other income/expenses net
-6,534
-283
554
2,608
4,691
Income before tax
-210,237
-287,100
135,707
92,775
-209,409
Income tax expense
0
0
3,463
2,942
-
Income from continuing operations
-210,237
-287,100
132,244
89,833
-209,409
Net income
-210,237
-287,100
132,244
89,833
-209,339
Net income available to common shareholders
-210,237
-287,100
132,244
89,833
-209,339
Basic EPS
-
-3.81
1.85
1.29
-3.22
Diluted EPS
-
-3.81
1.62
1.23
-3.22
Basic average shares
-
75,450
71,412
69,680
65,035
Diluted average shares
-
75,450
83,492
73,186
65,035
EBITDA
-
-260,687
159,761
113,635
-196,490